OTC Markets Group uses cookies and similar technologies to help us understand how you use our websites, as further disclosed in our Privacy Policy. Our Terms of Service contain important information including restrictions on your use of our websites. By clicking “Accept”, or by continuing to use our websites, you consent to the use of cookies and agree to the terms of the OTC Markets Group Privacy Policy and Terms of Service.
LMLLF
PHARMADRUG INC.
Ordinary Shares
0.0079
0.00
0.00%
0.007 / 0.0108 (1 x 1)
Real-Time Best Bid & Ask: 12:16pm 07/10/2025
Delayed (15 Min) Trade Data: 12:00am 07/08/2025
Warning! Limited Information
The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.0.00
N/A
0
N/A
Real-Time Level 2 Quote
Bid
Ask
MPID MPID | Bid Price Bid Price | Size Size | Time Time |
|---|---|---|---|
ETRF | 24.90 | >year | |
CDEL | 21.92 | 03/16 | |
MACM | 18.95 | >year | |
NITE | 18.95 | >year | |
CSTI | 18.55 | >year |
MPID MPID | Ask Price Ask Price | Size Size | Time Time |
|---|---|---|---|
INTL | 19.40 | >year | |
NITE | 19.40 | >year | |
MACM | 19.43 | >year | |
MAXM | 20.11 | >year | |
CANT | 22.05 | >year |
Unlock Real-Time quotes For LMLLFFind Out More
Trade Data
Date Date | Timestamp Timestamp | Price Price | $ Change $ Change | Volume Volume |
|---|---|---|---|---|
| 07/08/2025 | 13:03:18 | 0.0079 | -0.00 | 100 |
| 07/07/2025 | 10:54:31 | 0.0103 | -0.00 | 4,672 |
| 07/02/2025 | 15:47:38 | 0.0107 | 0.00 | 50,000 |
| 07/02/2025 | 15:33:12 | 0.01 | 0.00 | 51,557 |
| 07/02/2025 | 14:39:15 | 0.00865 | 0.00 | 10,000 |
News
PharmaDrug Announces Amendment to Shareholder Meeting MatterNewsfile | 09/19/2023
PharmaDrug Announces Appointment of CEO and Changes to the Board of DirectorsNewsfile | 09/06/2023
Filings and Disclosure
Company Description
PharmaDrug is a specialty pharmaceutical company focused on the research, development and commercialization of controlled-substances and natural medicines such as psychedelics and previously approved drugs. PharmaDrug owns 100% of Sairiyo Therapeutics ("Sairiyo"), a biotech company that specializes in researching and reformulating established natural medicines with a goal of bringing them through clinical trials and the associated regulatory approval process in the US and Europe. Sairiyo is currently developing its patented reformulation of cepharanthine, a drug that has shown substantial third party validated potential for the treatment of infectious disease (including Covid-19) and rare cancers. Sairiyo is also conducting R&D in the psychedelics space for the treatment of non-neuropsychiatric conditions.
Videos
This company has not added any videos
The Pink Limited Market is for broker-dealers to publicly quote securities with limited to no issuer involvement. Pink Limited companies do not certify their compliance with established reporting standards, have limited availability of disclosure or financial information and may not support their U.S. market. These securities are identified with a yield sign to warn investors to proceed with caution.
Pink Limited Information
The company’s transfer agent has verified its outstanding shares directly to OTC Markets.
Subscribe to Our Newsletter
Stay up to date on the latest company news, industry trends and regulatory changes that affect our markets and learn about members of our community.
Loading...
Symbol
OTCM
Last
59.25
Change
0.00 (0.00%)
Bid
58.00
Ask
59.24
Volume
1718
Time
11:49
